Uncertainties Threaten Venture-Capital-Backed Device Firms, MDMA Says
This article was originally published in The Gray Sheet
Executive Summary
Policy-makers can protect device manufacturers' access to venture capital by tackling regulatory uncertainties that interfere with VC firms' exit strategies, according to a report by the Medical Devices Manufacturers Association and the National Venture Capital Association